Advance Auto Parts numbers raised at GoldmanShares of AAP now seen reaching $49, according to Goldman Sachs. Estimates also increased, given higher buyback activity. Neutral rating.
Advance Auto Parts downgraded at UBSAAP was downgraded from Buy to Neutral, UBS said. $49 price target. Stock has outperformed its peers and the company is facing difficult comps in a period that saw adverse weather conditions.
Abovenet upgraded at WellsABVT was upgraded from Market Perform to Outperform, Wells Fargo said. Recent pullback has created an attractive buying opportunity.
Allergan upgraded at GoldmanAGN was upgraded from Neutral to Buy, Goldman Sachs said. Stock was also added to the Conviction Buy list, as the company has exposure to the aging and obesity markets.
AK Steel downgraded at LongbowAKS was downgraded from Buy to Neutral, Longbow Research said. Estimates also lowered, as the company faces higher iron ore prices.
Alaska Air Group downgraded at JP MorganALK downgraded at JP Morgan. Rating lowered to Neutral from Underweight. Price target raised to $36 from $34. 2010 EPS estimates raised to $6.79 from $6.23.
Airgas downgraded at Piper JaffrayARG downgraded at Piper Jaffray. Rating lowered to Neutral from Overweight. Price target lowered to $60 from $66. Fiscal 2011 EPS estimates lowered to $3.05 from $3.15.
Continental Resources downgraded at UBSCLR was downgraded from Buy to Neutral, UBS said. Valuation call, based on a $50 price target.
Cognizant Technology downgraded at GoldmanCTSH was downgraded from Buy to Neutral, Goldman Sachs said. Valuation call, based on a $57 price target. Even so, estimates were raised, because of higher sales expectations.
Delta Air Lines upgraded at JP MorganDAL upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $18.50 from $14.00. 2010 EPS estimates raised to $2.06 from $1.64.
EMC rated new Buy at Brean MurrayEMC was initiated with a Buy rating, Brean Murray said. $23 price target. See material upside earnings potential for the company.
Endo Pharmaceuticals upgraded at GoldmanENDP was upgraded from Neutral to Buy, Goldman Sachs said. Valuation call, as earnings should come in ahead of consensus expectations.
First Horizon National downgraded at BofA/MerrillFHN downgraded to Underperform from Neutral as estimates were reduced across the board, Bank of America/Merrill Lynch said. Price target lowered to $12 from $15. 2010 and 2011 EPS estimates sunk to -$0.40 and $0.40, respectively.
First Horizon National numbers increased at BarclaysFHN price target raised by a dollar to $15 after better than expected 1Q10, Barclays said. 2010 and 2011 EPS estimates improved to -$0.25 and $0.50, respectively. Maintain Equal Weight rating.
Forest Oil upgraded at GoldmanFST was upgraded from Neutral to Buy, Goldman Sachs said. Stock was also added to the Conviction List, as the stock has lagged since the company's analyst meeting. $34 price target.
Hill-Rom initiated Buy at BofA/MerrillHRC coverage initiated with a Buy rating and $38 price target, Bank of America/Merrill Lynch said. Margin expansion likely to drive significant EPS upside, analysts said. 2010 and 2011 EPS estimates sat at $1.32 and $1.57, respectively.
Janus Capital downgraded at JP MorganJNS downgraded at JP Morgan. Rating lowered to Underweight from Neutral. Price target raised to $15.00 from $14.50. 2010 EPS estimates raised to $0.79 from $0.75.
King Pharmaceuticals downgraded at GoldmanKG was downgraded from Outperform to Sell, Goldman Sachs said. See slowing growth and the need for the company to boost spending.
Lincoln Electric upgraded at Piper JaffrayLECO upgraded at Piper Jaffray. Rating raised to Overweight from Neutral. Price target raised to $70 from $55. 2010 EPS estimates raised to $2.65 from $2.50.
Lifepoint Hospitals downgraded at GoldmanLPNT was downgraded from Neutral to Sell, Goldman Sachs said. Valuation call, given the company's exposure to rural hospitals.
Lender Processing upgraded at GoldmanLPS was upgraded from Neutral to Buy, Goldman Sachs said. Estimates also boosted, as the default cycle should remain strong. $48 price target.
Southwest Airlines upgraded at JP MorganLUV upgraded at JP Morgan. Rating raised to Overweight from Underweight. Price target raised to $17 from $12. 2010 EPS estimates raised to $0.99 from $0.69.
Mohawk upgraded at SuntrustMHK was upgraded from Neutral to Buy, Suntrust Robinson Humphrey said. $80 price target. Company is seeing higher U.S. demand and is raising prices.
Medicis Pharmaceutical downgraded at GoldmanMRX was downgraded from Buy to Neutral, Goldman Sachs said. Valuation call, based on a $28 price target.
Palm downgraded at Morgan KeeganPALM was downgraded from Market Perform to Underperform, Morgan Keegan said. Company is losing key talent, which could hurt the prospects of a buyout,
Pool Corporation upgraded at Piper JaffrayPOOL upgraded at Piper Jaffray. Rating raised to Neutral from Underweight. Price target raised to $21 from $17. 2010 EPS estimates raised to $1.07 from $1.05.
Sprint-Nextel upgraded at WellsRating on S was boosted to Outperform, Wells Fargo said. Channel checks show that the company is seeing positive customer trends.
Suntech Power upgraded at ThinkEquitySTP was upgraded from Sell to Hold, ThinkEquity said. Estimates also boosted, as Germany will likely not cap solar subsidies.
Safeway downgraded at Credit Suisse SWY downgraded to Neutral from Outperform on valuation, Credit Suisse said. Price target maintained at $27. 2010 and 2011 EPS estimates held at $1.75 and $2.05, respectively.
T Rowe Price upgraded at JP MorganTROW upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $67 from $66. 2010 EPS estimates raised to $2.72 from $2.70.
TW Telecom downgraded at WellsTC was downgraded from Outperform to Market Perform, Wells Fargo said. Valuation call, as the stock is up 17% in the past 2 months.
Universal Health upgraded at GoldmanUHS was upgraded from Sell to Neutral, Goldman Sachs said. Estimates also boosted, because of lower bad-debt costs. $36 price target.
Shares of AAPl now seen reaching $305, Kaufman Bros. said. Estimates also increased, as the company will likely sell more iPhones. Buy rating.
Apache target cut, estimates higher at Barclays
APA price target trimmed by a dollar to $131 after the company announced a merger with Mariner Energy, Barclays said. 2010 and 2011 EPS estimates lifted to $9.40 and $9.70, respectively. Reiterate Overweight rating.
Apache target cut, estimates higher at Barclays APA price target trimmed by a dollar to $131 after the company announced a merger with Mariner Energy, Barclays said. 2010 and 2011 EPS estimates lifted to $9.40 and $9.70, respectively. Reiterate Overweight rating.
Atmel estimates, target raised at FBRShares of ATML now seen reaching $6, according to FBR Capital Markets. Estimates also increased, following strong channel checks. Outperform rating.
Bank of America target, estimates lifted at Citi BAC price target raised to $26 from $23 on 1Q10 results. Core PTPP shows strength in trading, Citigroup said. 2010 EPS estimates increased to $0.95, 2011 held at $2.00. Maintain Buy rating.
Bank of America target, estimates higher at BarclaysBAC price target raised by a dollar to $21 following decent 1Q10 results. Credit outlook good, Barclays said. 2010 and 2011 EPS estimates improved to $1.15 and $1.90, respectively. Equal Weight rating.
Bank of America estimates, target upped at UBSShares of BAC now seen reaching $21, according to UBS. Estimates also boosted, as the company is seeing better sales and credit trends. Buy rating.
Ciena target raised at UBSCIEN target was increased to $18, according to UBS. Company has a favorable product cycle and expect a positive upcoming analyst meeting. Neutral rating.
Cummins target, estimates higher at Credit SuisseCMI price target surged to $84 from $68, Credit Suisse said. 2011 and 2012 EPS estimates jumped to $4.25 and $6.00, respectively. Emerging markets still on fire, analysts said. Reiterate Outperform.
Coach estimates boosted at UBSCOH estimates were raised through 2011, UBS said. Company is seeing higher sale growth. Neutral rating and $39 price target.
Dell target, estimates boosted at BarclaysDELL price target raised by a dollar to $17 as PC sales forecast was lifted, Barclays said. 2011 and 2012 EPS estimates increased to $1.27 and $1.42, respectively. Maintain Equal Weight rating.
General Electric target, estimates higher at Barclays GE price target increased to $25 from $22 after a solid 1Q10 beat, Barclays said. GE Capital has turned the corner. 2010 EPS estimate lifted to $1.10, 2011 held at $1.40. Reiterate Overweight rating.
General Electric numbers increased at UBSGE estimates were boosted through 2011, UBS said. Company had strong earnings and credit metrics are improving. Neutral rating and new $19 price target.
Goldman Sachs cut from Top Picks list at FBRGS was removed from the Top Picks list, according to FBR Capital Markets. SEC actions will hang over the stock. Outperform rating and $190 price target.
Nasdaq estimates trimmed at UBSNDAQ estimates were lowered through 2011, UBS said. Company is seeing lower US cash and options volume. Neutral rating and $21 price target.
NRG Energy estimates boosted at Credit Suisse NRG 2010 and 2011 EPS estimates raised to $1.73 and $1.12, respectively. Potential for 1Q10 upside, Credit Suisse said. Reiterate Outperform rating and $30 price target.
NYSE Euronext estimates lowered at UBSNYX estimates were cut through 2011, UBS said. Company is seeing weaker volumes across the board. Buy rating and $33 price target.
OSI Pharmaceuticals price target boosted at BarclaysOSIP price target jumped to $67 from $64 following approval of Tarceva for NSCLC, Barclays said. Maintain Equal Weight rating.
Visa target boosted at UBSShares of V now seen reaching $110, UBS said. Company should post strong quarterly results, given easy comparisons. Outperform rating.
